Application 018303
- Type
- NDA
- Sponsor
- US PHARMS HOLDINGS I
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LOPRESSOR HCT | HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE | TABLET;ORAL | 25MG;50MG | Yes | No |
| 002 | LOPRESSOR HCT | HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE | TABLET;ORAL | 25MG;100MG | Yes | Yes |
| 003 | LOPRESSOR HCT | HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE | TABLET;ORAL | 50MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 30698-460 | Lopressor HCT | metoprolol tartrate and hydrochlorothiazide | Validus Pharmaceuticals LLC | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 77157 | SUPPL | 2023-12-27 |
| 77131 | SUPPL | 2023-12-27 |
| 71010 | SUPPL | 2022-05-06 |
| 70976 | SUPPL | 2022-05-04 |
| 64387 | SUPPL | 2020-08-24 |
| 64337 | SUPPL | 2020-08-21 |
| 33473 | SUPPL | 2011-03-21 |
| 11201 | SUPPL | 2011-03-21 |
| 896 | SUPPL | 2010-01-06 |
| 33472 | SUPPL | 2009-09-17 |
| 895 | SUPPL | 2008-08-13 |
| 33471 | SUPPL | 2008-07-29 |
| 14976 | SUPPL | 2008-01-09 |
| 11200 | SUPPL | 2008-01-08 |
| 894 | SUPPL | 2006-09-18 |
| 14975 | SUPPL | 2003-11-25 |